Related Experiment Videos
Procaine in malignant hyperpyrexia
British Medical Journal
|December 2, 1972
Summary
Procaine effectively reduces muscle contractures related to malignant hyperpyrexia, a condition exacerbated by halothane. This study supports procaine as a potential therapeutic agent for malignant hyperpyrexia.
Area of Science:
- Anesthesiology
- Pharmacology
- Human Physiology
Background:
- Malignant hyperpyrexia (MH) is a severe pharmacogenetic disorder of skeletal muscle.
- Caffeine contracture of human muscle serves as a model for MH.
- Halothane potentiates caffeine-induced muscle contracture.
Purpose of the Study:
- To investigate the effects of procaine and lignocaine on halothane-potentiated caffeine contracture in human muscle.
- To evaluate the efficacy of procaine in reversing MH-related muscle contractures.
Main Methods:
- Human muscle contracture experiments were conducted.
- The effects of halothane, caffeine, procaine, and lignocaine on muscle contractility were assessed.
- Muscle from an MH-susceptible patient was studied.
Main Results:
- Halothane significantly potentiated caffeine-induced contracture in normal human muscle.
- Procaine markedly reduced halothane-potentiated caffeine contracture and induced relaxation.
- Muscle from an MH-susceptible patient showed spontaneous contracture with halothane, reversed by procaine.
Conclusions:
- Procaine demonstrates significant efficacy in mitigating halothane-induced muscle contractures.
- These findings support the therapeutic application of procaine for managing malignant hyperpyrexia.